|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
109,840,000 |
Market
Cap: |
94.51(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.8942 - $2 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile OptiNose is a pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat and allergy specialists. Co.'s commercial product, XHANCE® (fluticasone propionate) nasal spray is a therapeutic utilizing its proprietary Exhalation Delivery System (EDS®) for the treatment of chronic rhinosinusitis with nasal polyps and. Co.'s solutions also include EDS, which enables the development of drug-device combination products intended for self-administration. Co. has developed both a liquid delivery EDS and a powder delivery EDS utilizing natural functional behaviors of the upper nasal airways intended to provide drug deposition.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
89,477 |
105,596 |
121,670 |
401,656 |
Total Sell Value |
$138,078 |
$156,615 |
$178,637 |
$979,259 |
Total People Sold |
3 |
3 |
3 |
6 |
Total Sell Transactions |
4 |
6 |
8 |
33 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Miller Peter K |
Chief Executive Officer |
|
2020-08-10 |
4 |
OE |
$1.63 |
$4,176 |
I/I |
2,562 |
2,562 |
|
- |
|
Miller Peter K |
Chief Executive Officer |
|
2020-08-10 |
4 |
D |
$7.00 |
$6,839 |
D/D |
(977) |
134,239 |
|
- |
|
Miller Peter K |
Chief Executive Officer |
|
2020-08-10 |
4 |
AS |
$7.00 |
$10,003 |
D/D |
(1,429) |
135,216 |
|
-39% |
|
Miller Peter K |
Chief Executive Officer |
|
2020-08-10 |
4 |
OE |
$1.63 |
$6,748 |
D/D |
4,140 |
136,645 |
|
- |
|
Oneil Robert P |
Director |
|
2020-03-09 |
4 |
B |
$5.30 |
$26,596 |
D/D |
5,000 |
7,000 |
2.39 |
-5% |
|
Goldan Keith A. |
Chief Financial Officer |
|
2020-03-06 |
4/A |
A |
$0.00 |
$0 |
D/D |
30,567 |
37,328 |
|
- |
|
Clavelli Victor M |
Chief Commercial Officer |
|
2020-03-06 |
4/A |
A |
$0.00 |
$0 |
D/D |
60,000 |
60,000 |
|
- |
|
Mahmoud Ramy A |
President and COO |
|
2020-03-06 |
4/A |
A |
$0.00 |
$0 |
D/D |
50,000 |
105,615 |
|
- |
|
Miller Peter K |
Chief Executive Officer |
|
2020-03-06 |
4/A |
A |
$0.00 |
$0 |
D/D |
133,333 |
265,838 |
|
- |
|
Marino Michael F Iii |
Chief Legal Officer & Corp Sec |
|
2020-03-06 |
4/A |
A |
$0.00 |
$0 |
D/D |
30,657 |
38,070 |
|
- |
|
Scodari Joseph C |
Director |
|
2020-03-06 |
4 |
B |
$5.53 |
$49,605 |
D/D |
8,700 |
21,230 |
2.39 |
-15% |
|
Scodari Joseph C |
Director |
|
2019-12-06 |
4 |
B |
$8.22 |
$50,142 |
D/D |
6,100 |
12,530 |
2.39 |
- |
|
Avista Capital Partners (offshore) Ii-A, Lp |
10% Owner |
|
2019-11-25 |
4 |
S |
$9.17 |
$11,456,250 |
I/I |
(1,250,000) |
807,995 |
|
- |
|
Venkataraman Sriram |
Director |
|
2019-11-25 |
4 |
S |
$9.17 |
$11,456,250 |
I/I |
(1,250,000) |
807,995 |
|
- |
|
Gibbs Thomas Edward |
Chief Commercial Officer |
|
2019-06-28 |
4 |
A |
$5.64 |
$15,612 |
D/D |
2,768 |
5,364 |
|
- |
|
Miller Peter K |
Chief Executive Officer |
|
2019-06-28 |
4 |
A |
$5.64 |
$22,740 |
D/D |
4,032 |
132,505 |
|
- |
|
Goldan Keith A. |
Chief Financial Officer |
|
2019-06-28 |
4 |
A |
$5.64 |
$5,307 |
D/D |
941 |
4,066 |
|
- |
|
Marino Michael F Iii |
Chief Legal Officer & Corp Sec |
|
2019-06-28 |
4 |
A |
$5.64 |
$22,740 |
D/D |
4,032 |
7,157 |
|
- |
|
Gibbs Thomas Edward |
Chief Commercial Officer |
|
2019-03-07 |
4 |
S |
$8.24 |
$16,480 |
D/D |
(2,000) |
2,596 |
|
- |
|
Miller Peter K |
Chief Executive Officer |
|
2018-12-13 |
4 |
B |
$7.68 |
$76,800 |
D/D |
10,000 |
127,738 |
2.81 |
- |
|
Scodari Joseph C |
Director |
|
2018-12-12 |
4 |
B |
$7.89 |
$50,733 |
D/D |
6,430 |
6,430 |
2.39 |
- |
|
Gibbs Thomas Edward |
Chief Commercial Officer |
|
2018-08-15 |
4 |
B |
$12.69 |
$25,380 |
D/D |
2,000 |
3,985 |
2.74 |
- |
|
Miller Peter K |
Chief Executive Officer |
|
2018-08-15 |
4 |
B |
$14.32 |
$153,969 |
D/D |
10,752 |
117,738 |
2.81 |
- |
|
Tkwd Ventures Llc |
10% Owner |
|
2018-06-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,195,914) |
817,225 |
|
- |
|
Wfd Ventures Llc |
10% Owner |
|
2018-06-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,195,914) |
817,225 |
|
- |
|
270 Records found
|
|
Page 10 of 11 |
|
|